Full title: A Study of Ripretinib Vs Sunitinib in Patients with Advanced GIST with Specific KIT Exon Mutations Who Were Previously Treated with Imatinib (INSIGHT)
Age: 18+
Phase: 3
Locations:
- London – Royal Marsden Hospital
- Leeds – St James University Hospital
This study will compare the effect of a drug called ripretinib to a drug called sunitinib to see which has the better outcomes for patients with GIST who have specific mutations and who previously had treatment with imatinib.
More information can be found at clinicaltrials.gov
To find out more about this trial and whether you could take part, talk to your clinical team.
